25,000+cancers found; 1 in 3 referrals cleared same day
Because of AI, about a third of urgent skin-cancer referrals at some NHS hospitals got a same-day all-clear without waiting weeks for a dermatologist.
Skin Analytics' DERM, the only AI with Class III CE certification for autonomous use, has assessed 250,000+ NHS patients, identified 25,000+ histology-confirmed cancers, and is expanding to all 18 NHS South East trusts (about 9 million more people) from autumn 2026.
Sources
- primaryNICE early value assessment HTE24, 1 May 2025 (now HTG746, updated 17 March 2026): AI technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathwaynice.org.uk
- primaryNIHR HTA: DERM and Moleanalyzer Pro clinical and cost-effectiveness (Feb 2026)njl-admin.nihr.ac.uk
- primaryBJD abstract: implementing DERM at an NHS district hospitalcitedrive.com
- secondaryHealth Tech Digital report on the NICE assessment (May 2025)healthtechdigital.com
- secondaryHLTH: NHS South East expands DERM across 18 trustshlth.com
History
- NICE guidance page is now the primary for the early value assessment; the news article that stood in for it is secondary.
- Poster number and label set from the entry's own figures.
- Added.
Cite this entry
Permalink https://becauseofai.org/entry/nhs-derm-skin-cancer
“Because of AI, about a third of urgent skin-cancer referrals at some NHS hospitals got a same-day all-clear without waiting weeks for a dermatologist.” Because of AI, updated Oct 22, 2026. https://becauseofai.org/entry/nhs-derm-skin-cancer@misc{becauseofai_nhs_derm_skin_cancer,
title = {Because of AI, about a third of urgent skin-cancer referrals at some NHS hospitals got a same-day all-clear without waiting weeks for a dermatologist.},
howpublished = {\url{https://becauseofai.org/entry/nhs-derm-skin-cancer}},
note = {Because of AI registry, updated Oct 22, 2026},
year = {2026}
}